Assenagon Asset Management S.A.

Position in EOLS — Evolus, Inc.

CIK 1546007 SENNINGERBERG, N4

Back to EOLS Full portfolio

Position in EOLS

as of Jun 30, 2026 · filed Jul 8, 2026 Compact

Position Value

$6,302,769

+$3,844,394 QoQ

Shares Held

908,180

+51.8% QoQ

Ownership

1.38%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

of 23 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in EOLS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Assenagon Asset Management S.A. holds $514,912,865 across 20 Drug Manufacturers - Specialty & Generic names. EOLS ranks #10 (1.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TEVA	Teva Pharmaceutical Industries Ltd	3,056,017	$103,537,855
2	LNTH	Lantheus Holdings, Inc.	714,980	$79,319,881
3	VTRS	Viatris Inc	4,989,006	$79,225,415
4	INDV	Indivior Pharmaceuticals, Inc.	1,540,928	$63,224,275
5	UTHR	UNITED THERAPEUTICS Corp	84,538	$45,805,224
6	AMRX	Amneal Pharmaceuticals, Inc.	2,445,549	$42,332,453
7	NBIX	Neurocrine Biosciences Inc	222,606	$37,518,015
8	ZTS	Zoetis Inc.	389,335	$27,977,613

All Filings in EOLS

Export CSV

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,302,769	908,180	+51.8%	Shares	Sole	2026-07-08
2026-03-31	$2,458,375	598,145	+121.4%	Shares	Sole	2026-04-20
2025-12-31	$1,796,956	270,219	-5.4%	Shares	Sole	2026-01-09
2025-09-30	$1,754,701	285,782	-53.3%	Shares	Sole	2025-10-07
2025-06-30	$5,640,093	612,388	-13.8%	Shares	Sole	2025-07-11
2025-03-31	$8,549,877	710,713	+63.2%	Shares	Sole	2025-04-15
2024-12-31	$4,807,401	435,453	-54.4%	Shares	Sole	2025-01-14
2024-09-30	$15,479,991	955,555	+0.9%	Shares	Sole	2024-10-23
2024-06-30	$10,276,067	947,103	+5627.2%	Shares	Sole	2024-07-18
2024-03-31	$231,518	16,537	—	Shares	Sole	2024-04-24
No filing history on record for this holder in this stock.